Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HemaCenter is a U.S.-based blood and leukapheresis collection business that supplies adult whole blood- and peripheral blood-derived cellular starting materials to cell therapy developers and medical researchers. The company focuses on donor recruitment and collection of leukocytes and leukopaks used to support the development of cell-based therapies and related biomedical research. HemaCenter operates as a wholly owned subsidiary of OrganaBio and appears to function as part of OrganaBio's vertically integrated cell therapy supply chain. Its activities are commercial service and supply operations rather than proprietary therapeutic drug development. The business is positioned at the interface of donor sourcing, apheresis collection, and provision of research- and clinical-use cellular materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HemaCenter.